Adult incontinence products are reimbursed in Latvia for a set list of diagnosed conditions. Patients diagnosed with these conditions are eligible to a 50% reimbursement from the state for up to three units of adult incontinence. The state support mechanism is implemented as a subsidy to drugstores for prescriptions turned in by patients. Thus, patients need a prescription from a doctor to receive the reimbursement. As any items included in the subsidy system also need to be approved for support...

Euromonitor International’s Rx/Reimbursement adult incontinence in Latvia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2023 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years’ experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.